Pfiz­er starts re­open­ing of tor­na­do-dam­aged Rocky Mount plant, eyes Q4 for full op­er­a­tions

Pfiz­er has be­gun to re­open its tor­na­do-im­pact­ed fa­cil­i­ty in Rocky Mount, with the com­pa­ny fore­cast­ing it would be ful­ly op­er­a­tional by the fourth quar­ter.

On Ju­ly 19, Pfiz­er halt­ed pro­duc­tion and man­u­fac­tur­ing in its 1.4 mil­lion-square-foot fa­cil­i­ty in North Car­oli­na as it was hit by an EF-3 tor­na­do, pri­mar­i­ly dam­ag­ing the site ware­house.

Be­cause the site man­u­fac­tures near­ly a quar­ter of ster­ile in­jecta­bles used in US hos­pi­tals, there were con­cerns over short­ages. Pfiz­er sub­se­quent­ly placed a dozen prod­ucts on emer­gency or­der to ac­com­mo­date dis­tri­b­u­tion is­sues.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER